The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,6-difluoro-3-((1-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)heptan-2-yl)oxy)benzamide ID: ALA5091931
PubChem CID: 166635793
Max Phase: Preclinical
Molecular Formula: C20H21F2N5O5
Molecular Weight: 449.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCC(CNc1ccc([N+](=O)[O-])c2nonc12)Oc1ccc(F)c(C(N)=O)c1F
Standard InChI: InChI=1S/C20H21F2N5O5/c1-2-3-4-5-11(31-15-9-6-12(21)16(17(15)22)20(23)28)10-24-13-7-8-14(27(29)30)19-18(13)25-32-26-19/h6-9,11,24H,2-5,10H2,1H3,(H2,23,28)
Standard InChI Key: DHOIGLJPZWVCRG-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
2.3492 -15.6628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3481 -16.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0593 -16.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7763 -16.4897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7735 -15.6592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0575 -15.2522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0546 -14.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7685 -14.0067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3425 -14.0109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4870 -15.2462 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6341 -15.2526 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.4920 -16.9032 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2064 -16.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9222 -16.9010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6365 -16.4853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3522 -16.8988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3491 -17.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0640 -18.1337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7751 -17.7221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0599 -16.4831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7700 -16.8887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3753 -16.3333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0368 -15.5870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2224 -15.6797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4936 -18.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2072 -17.7161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4966 -18.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2051 -15.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9195 -15.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9182 -14.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6326 -14.0102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6313 -13.1852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 9 2 0
6 7 1 0
5 10 1 0
1 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 21 1 0
20 16 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 20 2 0
25 26 2 0
25 27 1 0
19 25 1 0
13 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.41Molecular Weight (Monoisotopic): 449.1511AlogP: 3.95#Rotatable Bonds: 11Polar Surface Area: 146.41Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.96CX Basic pKa: ┄CX LogP: 3.79CX LogD: 3.79Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.25Np Likeness Score: -1.04
References 1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781 ] [10.1021/acs.jmedchem.0c02207 ]